Suchergebnisse - "ulcerative colitis."

PubPharm (96)

1

De-escalation of Biologic Treatment in Inflammatory Bowel Disease : A Comprehensive Review

enthalten in: Journal of Crohn's & colitis | 2024

von Gisbert, J. | Chaparro, M.

2

Combination treatment of inflammatory bowel disease : Present status and future perspectives

enthalten in: World journal of gastroenterology | 2024

von Triantafillidis, J. | Zografos, C. | Konstadoulakis, M. | +1

3

Medical Management of Inflammatory Bowel Disease

enthalten in: The Surgical clinics of North America | 2024

von Rahman, S. | Patel, R. | Boden, E. | +1

4

Prognosis of pediatric ulcerative colitis after infliximab failure : A multicenter registry-based cohort study

enthalten in: Journal of gastroenterology and hepatology | 2024

von Nambu, R. | Kudo, T. | Tachibana, N. | +25

5

An update on the safety of long-term vedolizumab use in inflammatory bowel disease

enthalten in: Expert opinion on drug safety | 2023

von Honap, S. | Netter, P. | Danese, S. | +1

6

Switching from intravenous to subcutaneous vedolizumab maintenance treatment in patients with inflammatory bowel disease followed by therapeutic drug monitoring

enthalten in: Scandinavian journal of gastroenterology | 2023

von Wiken, T. | Høivik, M. | Buer, L. | +6

7

Vedolizumab and Adalimumab in Biologic-Naïve Ulcerative Colitis : Comparison of Patient-Level Clinical Trial Data and VARSITY for Week 6 Clinical Remission

enthalten in: Digestive diseases and sciences | 2023

von Narula, N. | Wong, E. | Dulai, P. | +3

8

Definition of a therapeutic range for predicting long-term infliximab response in patients with inflammatory bowel disease

enthalten in: Medicina clinica | 2023

von Cantarelli, L. | Carrillo Palau, M. | Hernandez Guerra, M. | +2

9

Treatment persistence of ustekinumab and vedolizumab in IBD patients is independent of prior immunogenicity to anti-TNFs : a retrospective study

enthalten in: Scandinavian journal of gastroenterology | 2022

von Blesl, A. | Petritsch, W. | Binder, L. | +5

10

Efficacy and Safety of Elective Switching from Intravenous to Subcutaneous Infliximab [CT-P13] : A Multicentre Cohort Study

enthalten in: Journal of Crohn's & colitis | 2022

von Smith, P. | Critchley, L. | Storey, D. | +17

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]